Explore more publications!

Press Releases

Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas
Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory  Idiopathic Intracranial Hypertension (IIH)
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
Circana Research Reveals U.S. Private Label CPG Sales Reach $330 Billion
Housing Insecurity Emerges as Most Pressing Need Across the U.S., New 211 Data Shows
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone
Over $1.75M Raised for OC’s Unhoused Families at Illumination Health + Home’s Chef’s Table Gala
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Mama’s Creations to Host Fourth Quarter Fiscal 2026 Earnings Call on April 14 at 4:30 p.m. Eastern Time
GAGE Launches the World’s First Workforce Community Connecting Employees and Employers
Global Soft Drink Concentrates Market North America Leads with Coca-Cola & PepsiCo Driving Growth Trends
ISO 9001 Consulting Firms Report U.S. Businesses Leave Money on the Table-$6 Revenue per $1 Spent on Quality Management
Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout
American Hotel Income Properties REIT LP Reports Q4 2025 Results, Improved Balance Sheet and Demonstrated Hotel Value
U.S. Ambulatory Surgery Center Market Analysis of Size, Shares, Business Growth, and Upcoming Trends Forecast 2026-2033
Ozop Energy Solutions, Inc. Highlights Second NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Beyond Oil Expands into U.S. Supermarket Vertical with Multi-Phase Commercial Rollout with a Top-Tier U.S. Supermarket Brand
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions